http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 29 Apr 2026 11:17:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> On 29 April 2026, Vetoquinol (Paris:VETO) filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). </p><p> The 2025 Universal Registration Document in ESEF and PDF formats (reproduction of the official version of the Universal Registration Document in ESEF format) is available to the public under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Vetoquinol laboratory website (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vetoquinol.com&amp;esheet=54525470&amp;newsitemid=20260429633198&amp;lan=en-US&amp;anchor=www.vetoquinol.com&amp;index=1&amp;md5=3a4e1f423cdf1e5d3c4eb060af638f2d" shape="rect">www.vetoquinol.com</a>), in the “Regulated Information” section. It is also available on the AMF’s website (<a target="_blank" rel="nofollow" http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html Wed, 29 Apr 2026 11:17:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> On 29 April 2026, Vetoquinol (Paris:VETO) filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). </p><p> The 2025 Universal Registration Document in ESEF and PDF formats (reproduction of the official version of the Universal Registration Document in ESEF format) is available to the public under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Vetoquinol laboratory website (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vetoquinol.com&amp;esheet=54525470&amp;newsitemid=20260429633198&amp;lan=en-US&amp;anchor=www.vetoquinol.com&amp;index=1&amp;md5=3a4e1f423cdf1e5d3c4eb060af638f2d" shape="rect">www.vetoquinol.com</a>), in the “Regulated Information” section. It is also available on the AMF’s website (<a target="_blank" rel="nofollow" http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html Wed, 29 Apr 2026 11:17:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> On 29 April 2026, Vetoquinol (Paris:VETO) filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). </p><p> The 2025 Universal Registration Document in ESEF and PDF formats (reproduction of the official version of the Universal Registration Document in ESEF format) is available to the public under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Vetoquinol laboratory website (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vetoquinol.com&amp;esheet=54525470&amp;newsitemid=20260429633198&amp;lan=en-US&amp;anchor=www.vetoquinol.com&amp;index=1&amp;md5=3a4e1f423cdf1e5d3c4eb060af638f2d" shape="rect">www.vetoquinol.com</a>), in the “Regulated Information” section. It is also available on the AMF’s website (<a target="_blank" rel="nofollow" http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html Wed, 29 Apr 2026 11:17:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> On 29 April 2026, Vetoquinol (Paris:VETO) filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). </p><p> The 2025 Universal Registration Document in ESEF and PDF formats (reproduction of the official version of the Universal Registration Document in ESEF format) is available to the public under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Vetoquinol laboratory website (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vetoquinol.com&amp;esheet=54525470&amp;newsitemid=20260429633198&amp;lan=en-US&amp;anchor=www.vetoquinol.com&amp;index=1&amp;md5=3a4e1f423cdf1e5d3c4eb060af638f2d" shape="rect">www.vetoquinol.com</a>), in the “Regulated Information” section. It is also available on the AMF’s website (<a target="_blank" rel="nofollow" http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html Wed, 29 Apr 2026 11:17:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> On 29 April 2026, Vetoquinol (Paris:VETO) filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). </p><p> The 2025 Universal Registration Document in ESEF and PDF formats (reproduction of the official version of the Universal Registration Document in ESEF format) is available to the public under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Vetoquinol laboratory website (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vetoquinol.com&amp;esheet=54525470&amp;newsitemid=20260429633198&amp;lan=en-US&amp;anchor=www.vetoquinol.com&amp;index=1&amp;md5=3a4e1f423cdf1e5d3c4eb060af638f2d" shape="rect">www.vetoquinol.com</a>), in the “Regulated Information” section. It is also available on the AMF’s website (<a target="_blank" rel="nofollow" http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html Wed, 29 Apr 2026 11:17:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> On 29 April 2026, Vetoquinol (Paris:VETO) filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). </p><p> The 2025 Universal Registration Document in ESEF and PDF formats (reproduction of the official version of the Universal Registration Document in ESEF format) is available to the public under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Vetoquinol laboratory website (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vetoquinol.com&amp;esheet=54525470&amp;newsitemid=20260429633198&amp;lan=en-US&amp;anchor=www.vetoquinol.com&amp;index=1&amp;md5=3a4e1f423cdf1e5d3c4eb060af638f2d" shape="rect">www.vetoquinol.com</a>), in the “Regulated Information” section. It is also available on the AMF’s website (<a target="_blank" rel="nofollow" http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html Wed, 29 Apr 2026 11:17:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> On 29 April 2026, Vetoquinol (Paris:VETO) filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). </p><p> The 2025 Universal Registration Document in ESEF and PDF formats (reproduction of the official version of the Universal Registration Document in ESEF format) is available to the public under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Vetoquinol laboratory website (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vetoquinol.com&amp;esheet=54525470&amp;newsitemid=20260429633198&amp;lan=en-US&amp;anchor=www.vetoquinol.com&amp;index=1&amp;md5=3a4e1f423cdf1e5d3c4eb060af638f2d" shape="rect">www.vetoquinol.com</a>), in the “Regulated Information” section. It is also available on the AMF’s website (<a target="_blank" rel="nofollow" http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html Wed, 29 Apr 2026 11:17:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> On 29 April 2026, Vetoquinol (Paris:VETO) filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). </p><p> The 2025 Universal Registration Document in ESEF and PDF formats (reproduction of the official version of the Universal Registration Document in ESEF format) is available to the public under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Vetoquinol laboratory website (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vetoquinol.com&amp;esheet=54525470&amp;newsitemid=20260429633198&amp;lan=en-US&amp;anchor=www.vetoquinol.com&amp;index=1&amp;md5=3a4e1f423cdf1e5d3c4eb060af638f2d" shape="rect">www.vetoquinol.com</a>), in the “Regulated Information” section. It is also available on the AMF’s website (<a target="_blank" rel="nofollow" http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Availability+of+the+2025+Universal+Registration+Document/26390823.html Wed, 29 Apr 2026 11:17:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html <p> <b>Sales: €125 million -0.3% at constant exchange rates</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Vetoquinol (Paris:VETO): </p><p> <b>Sales for the first quarter of 2026 amounted to €125 million, </b>down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. </p><p> The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html Tue, 28 Apr 2026 11:45:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html <p> <b>Sales: €125 million -0.3% at constant exchange rates</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Vetoquinol (Paris:VETO): </p><p> <b>Sales for the first quarter of 2026 amounted to €125 million, </b>down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. </p><p> The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html Tue, 28 Apr 2026 11:45:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html <p> <b>Sales: €125 million -0.3% at constant exchange rates</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Vetoquinol (Paris:VETO): </p><p> <b>Sales for the first quarter of 2026 amounted to €125 million, </b>down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. </p><p> The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html Tue, 28 Apr 2026 11:45:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html <p> <b>Sales: €125 million -0.3% at constant exchange rates</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Vetoquinol (Paris:VETO): </p><p> <b>Sales for the first quarter of 2026 amounted to €125 million, </b>down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. </p><p> The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html Tue, 28 Apr 2026 11:45:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html <p> <b>Sales: €125 million -0.3% at constant exchange rates</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Vetoquinol (Paris:VETO): </p><p> <b>Sales for the first quarter of 2026 amounted to €125 million, </b>down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. </p><p> The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html Tue, 28 Apr 2026 11:45:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html <p> <b>Sales: €125 million -0.3% at constant exchange rates</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Vetoquinol (Paris:VETO): </p><p> <b>Sales for the first quarter of 2026 amounted to €125 million, </b>down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. </p><p> The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html Tue, 28 Apr 2026 11:45:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html <p> <b>Sales: €125 million -0.3% at constant exchange rates</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Vetoquinol (Paris:VETO): </p><p> <b>Sales for the first quarter of 2026 amounted to €125 million, </b>down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. </p><p> The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html Tue, 28 Apr 2026 11:45:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html <p> <b>Sales: €125 million -0.3% at constant exchange rates</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Vetoquinol (Paris:VETO): </p><p> <b>Sales for the first quarter of 2026 amounted to €125 million, </b>down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. </p><p> The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+Sales+for+1st+Quarter+2026/26381396.html Tue, 28 Apr 2026 11:45:00 -0400 A.32597436 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Press+Releases/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+2025+Annual+Results/26226877.html <p> <b>Annual sales: €526 m </b>(+0.2% at constant exchange rates) <br></br><b>Essential Products sales: €334 m </b>(+4.1% at constant exchange rates) <br></br><b>EBIT before amortization of acquired assets: €92 m </b>(17.4% of sales) <br></br><b>Net result, Group share: €57 m </b>(10.9% of sales) <br></br><b>Cash flow generation: €72 m</b> </p> <p> LURE, France--(BUSINESS WIRE)-- Regulatory News: </p><p> Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, <i>“In an extremely volatile environment, Vetoquinol has once again this year demonstrated the resilience of its business model, driven by a long-term strategic vision which, combined with our proactive management of expenses, enables us to deliver a healthy level http://www.streetinsider.com/Business+Wire/Vetoquinol%3A+2025+Annual+Results/26226877.html Fri, 27 Mar 2026 03:15:00 -0400 A.32597436 A.50203723 O.00003755 O.00368029 O.00386911 VETO